Trial Profile
The Effect of Melatonin on Memory and Other Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment (MCI): A Placebo- Controlled Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Melatonin (Primary)
- Indications Mild cognitive impairment
- Focus Therapeutic Use
- 14 Nov 2007 New trial record.